20Breast cancer is the second-leading cause of cancer-related deaths in women in the 21 United States. Triple-negative breast cancer constitutes a subset of breast cancer that is 22
Importance 38Patients afflicted by triple-negative breast cancer have decreased survival and limited 39 therapeutic options. Reovirus infection results in cell death of a variety of cancers, but it is 40 unknown if different reovirus types lead to triple-negative breast cancer cell death. In this study, 41 we generated two novel reoviruses that more efficiently infect and kill triple-negative breast 42 cancer cells. We show that infection in the presence of DNA-damaging agents enhances 43 infection and triple-negative breast cancer cell killing by reovirus. These data suggest that a 44 combination of a genetically engineered oncolytic reovirus and topoisomerase inhibitors may 45 provide a potent therapeutic option for patients afflicted with triple-negative breast cancer. 46 47Breast cancer is the leading cause of cancer and second leading cause of deaths by cancer 48 in women in the United States (1). Triple-negative breast cancer (TNBC) constitutes 49 approximately 15% of breast cancers, has a higher rate of relapse, and shorter overall survival 50 after metastasis than other subtypes of breast cancer (2). TNBC more frequently affects the 51 young, is more prevalent in African American women, and tumors are larger in size and 52 biologically more aggressive (3). TNBC is characterized by the lack of expression of estrogen 53 receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 54 (HER2/neu) and can be classified into seven subtypes based on their genetic signature (3). 55